• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Exploring mental health-related emergency department visits

Exploring mental health-related emergency department visits

by Truveta Research | Dec 21, 2024 | Research, Research Insights

In an exclusive analysis for the Wall Street Journal, Truveta Research explored mental health-related emergency department visits. The rate of ED encounters related to mental health conditions peaked in 2021 for all conditions studied, besides schizophrenia, which...
Real-time monitoring of respiratory virus-associated hospitalizations: Trends through November 2024 

Real-time monitoring of respiratory virus-associated hospitalizations: Trends through November 2024 

by Truveta staff | Dec 19, 2024 | Research

Between the last week of October and the last week of November, there was a 58.8% increase in respiratory virus-associated hospitalizations. For infants and children under the age of 5, respiratory viruses are now associated with 7.9% of hospitalizations in this...
Exploring first-time GLP-1 prescriptions and new comorbidity diagnoses

Exploring first-time GLP-1 prescriptions and new comorbidity diagnoses

by Truveta Research | Dec 16, 2024 | Research, Research Insights

In partnership with Reuters, Truveta Research explored the percentage of patients who received a first-time diagnosis of type 2 diabetes, cardiovascular disease, or sleep apnea within 15 days of their first-time GLP-1 prescriptions. Truveta Research found that for...
Adderall shortage: Exploring first-time Adderall prescriptions and fill rates

Adderall shortage: Exploring first-time Adderall prescriptions and fill rates

by Truveta Research | Dec 14, 2024 | Research, Research Insights

First-time amphetamine/dextroamphetamine prescription rates remained stable overall, but increased significantly for people 30-44, 45-64, and 65+ years of age. The percentage of prescriptions filled within 5 days of being written reached their lowest values in March...
Adderall shortage: Exploring first-time ADHD diagnosis rates

Adderall shortage: Exploring first-time ADHD diagnosis rates

by Truveta Research | Dec 11, 2024 | Research, Research Insights

The rate of first-time ADHD diagnoses has increased since 2021. The largest increases in first-time ADHD diagnosis rates were seen in the 30-44-year-old and 45-64-year-old age groups. Age groups under 30 years old did not see increases in first-time ADHD diagnosis...
Combating respiratory viruses with EHR data: Key use cases for life sciences and public health

Combating respiratory viruses with EHR data: Key use cases for life sciences and public health

by Truveta staff | Dec 10, 2024 | Research

“For the first time in the history of health, we have enough data at scale to dramatically advance innovation in healthcare” – Michael Slubowski, president & CEO, Trinity Health  Electronic health record (EHR) data is rapidly changing how life sciences,...
« Older Entries
Next Entries »

Share this


Recent posts

  • Real-time monitoring of respiratory virus-associated hospitalizations: Trends through November 2025 
  • Rising use of GLP-1 medications among women with PCOS
  • Advancing biomedical AI: Enhancing BERT performance with LLM-generated annotations

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.